HCID 58504435, compound → HCID 58504523, compound
Reaction equation
[N:1]([CH2:4][C@H:5]1[O:10][CH2:9][C@@H:8]([CH3:11])[N:7]([C:12]2[CH:17]=[C:16]([Cl:18])[N:15]=[C:14]([NH2:19])[N:13]=2)[CH2:6]1)=[N+]=[N-]>C(O)C.[Pd]>[NH2:1][CH2:4][C@H:5]1[O:10][CH2:9][C@@H:8]([CH3:11])[N:7]([C:12]2[CH:17]=[C:16]([Cl:18])[N:15]=[C:14]([NH2:19])[N:13]=2)[CH2:6]1Participants
4
Reactant 1
Product 1
Reagents, catalysts & solvents 2
Procedure
A suspension of 4-[(2S,5R)-2-(azidomethyl)-5-methyl-4-morpholinyl]-6-chloro-2-pyrimidinamine (890 mg, 3.14 mmol) and 10% Pd/C (95 mg, 0.09 mmol) in ethanol (35 mL) was stirred under an atmosphere of hydrogen for 1.5 hours, then filtered through a pad of celite. The filtrate was concentrated in vacuo to give the title compound (778 mg, about 85% purity) as a white solid. LC-MS (ES) m/z=258, 260 [M+H]+.
Workup
- filtrationfiltered through a pad of celite
- concentrationThe filtrate was concentrated in vacuo
Sources & evidence
- ORD record
- ord-23f4b89e64da4e0282c1778f9fc7c4d4
- Source dataset
- uspto-grants-2014_04
- Patent number
- US08697685B2
Reaction notes
Loading…